T0	Outcomes 0 24	Effectiveness and Safety
T1	Outcomes 268 298	effectiveness and tolerability
T2	Outcomes 698 724	decrease in pain intensity
T3	Outcomes 729 751	average pain intensity
T4	Outcomes 932 946	(n = 288), the
T5	Outcomes 1056 1072	on the change in
T6	Outcomes 1182 1202	for noninferiority).
T7	Outcomes 1203 1239	Neuropathic pain and quality-of-life
T8	Outcomes 1258 1286	significantly in both groups
T9	Outcomes 1555 1584	of the composite of dizziness
T10	Outcomes 1741 1818	associated with comparable improvements in pain intensity and quality-of-life
T11	Outcomes 1845 1900	300 mg/pregabalin 300 mg, with improved central nervous